Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

147 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Evaluation of a functional index and an articular index in ankylosing spondylitis.
Dougados M, Gueguen A, Nakache JP, Nguyen M, Mery C, Amor B. Dougados M, et al. J Rheumatol. 1988 Feb;15(2):302-7. J Rheumatol. 1988. PMID: 3283358 Clinical Trial.
We describe an index of functional impairment and a system of scoring joint tenderness for use in the assessment of ankylosing spondylitis. The functional index consists of 20 questions and the articular index is based on the scoring of a total of 10 joint responses …
We describe an index of functional impairment and a system of scoring joint tenderness for use in the assessment of ankylosing spondy …
Relevant change in radiological progression in patients with hip osteoarthritis. II. Determination using an expert opinion approach.
Maillefert JF, Nguyen M, Gueguen A, Berdah L, Lequesne M, Mazières B, Vignon E, Dougados M. Maillefert JF, et al. Rheumatology (Oxford). 2002 Feb;41(2):148-52. doi: 10.1093/rheumatology/41.2.148. Rheumatology (Oxford). 2002. PMID: 11886962 Clinical Trial.
METHODS: A sample of 298 patients with hip OA was selected from a multicentre, prospective, longitudinal, 3-yr follow-up study. A pelvic radiograph was obtained at entry and after 3 yr. For each film, the narrowest JSW was measured using a 0.1-mm gradu …
METHODS: A sample of 298 patients with hip OA was selected from a multicentre, prospective, longitudinal, 3-yr follow-up study …
Requirement for total hip arthroplasty: an outcome measure of hip osteoarthritis?
Dougados M, Gueguen A, Nguyen M, Berdah L, Lequesne M, Mazieres B, Vignon E. Dougados M, et al. J Rheumatol. 1999 Apr;26(4):855-61. J Rheumatol. 1999. PMID: 10229407 Clinical Trial.
OBJECTIVE: To assess if total hip arthroplasty (THA) is a valid outcome measure of hip osteoarthritis (OA), in respect to clinical and radiological assessments. METHODS: A prospective 3 year study of patients who had painful hip OA with an initial radiographic joint …
OBJECTIVE: To assess if total hip arthroplasty (THA) is a valid outcome measure of hip osteoarthritis (OA), in respect to clinical an …
Radiological progression of hip osteoarthritis: definition, risk factors and correlations with clinical status.
Dougados M, Gueguen A, Nguyen M, Berdah L, Lequesne M, Mazieres B, Vignon E. Dougados M, et al. Ann Rheum Dis. 1996 Jun;55(6):356-62. doi: 10.1136/ard.55.6.356. Ann Rheum Dis. 1996. PMID: 8694574 Free PMC article. Clinical Trial.
METHODS: A prospective, longitudinal (one year duration), multicentre study was made of patients with osteoarthritis of the hip (American College of Rheumatology criteria). ...RESULTS: Analysis of the means of the differences between two analyses performed by a sing …
METHODS: A prospective, longitudinal (one year duration), multicentre study was made of patients with osteoarthritis of the hip (Amer …
Features associated with juvenile onset of spondylarthropathies in north Africa.
Claudepierre P, Gueguen A, Ladjouze A, Hajjaj-Hassouni N, Sellami S, Amor B, Dougados M. Claudepierre P, et al. Rev Rhum Engl Ed. 1996 Feb;63(2):87-91. Rev Rhum Engl Ed. 1996. PMID: 8689293 Clinical Trial.
Demographic data and clinical findings at the time of inclusion and during the first two years of the disease were compared in the 437 patients with onset at 16 years of age or older and in the 86 patients with onset before 16 years of age using a Student's t test or a
Demographic data and clinical findings at the time of inclusion and during the first two years of the disease were compared in the 437 patie …
Predictive factors of severity of spondyloarthropathy in North Africa.
Claudepierre P, Gueguen A, Ladjouze A, Hajjaj-Hassouni N, Sellami S, Amor B, Dougados M. Claudepierre P, et al. Br J Rheumatol. 1995 Dec;34(12):1139-45. doi: 10.1093/rheumatology/34.12.1139. Br J Rheumatol. 1995. PMID: 8608355
Hip involvement, which may be used as a marker of disease severity, is more frequent in spondyloarthropathies developed in North Africa. ...The predictive value of each variable with regard to time to hip involvement was evaluated using a uni- and then a mult …
Hip involvement, which may be used as a marker of disease severity, is more frequent in spondyloarthropathies developed in North Afri …
The SFA system for assessing articular cartilage lesions at arthroscopy of the knee.
Dougados M, Ayral X, Listrat V, Gueguen A, Bahuaud J, Beaufils P, Beguin JA, Bonvarlet JP, Boyer T, Coudane H, et al. Dougados M, et al. Arthroscopy. 1994 Feb;10(1):69-77. doi: 10.1016/s0749-8063(05)80295-6. Arthroscopy. 1994. PMID: 8166905 Clinical Trial.
Criteria for assessment of severity of chondropathy were as follows: (a) Physician's overall assessment using a 100-mm-long Visual Analogue Scale, and (b) size, grade, and localization of cartilage lesions recorded on a diagram. ...The analyses resulted in tw …
Criteria for assessment of severity of chondropathy were as follows: (a) Physician's overall assessment using a 100-mm-long Vi …
Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial.
Dougados M, Gueguen A, Nakache JP, Velicitat P, Veys EM, Zeidler H, Calin A. Dougados M, et al. Rheumatology (Oxford). 1999 Mar;38(3):235-44. doi: 10.1093/rheumatology/38.3.235. Rheumatology (Oxford). 1999. PMID: 10325662 Clinical Trial.
METHODS: The design was a prospective, multicentre, double-blind, placebo-controlled study of 6 weeks duration with a 12 months double-blind extension. ...CONCLUSION: This study suggests that a 1 yr trial might be of optimum value compared to a 6 week …
METHODS: The design was a prospective, multicentre, double-blind, placebo-controlled study of 6 weeks duration with a 12 month …
Outcome variables in ankylosing spondylitis: evaluation of their relevance and discriminant capacity.
Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M. Calin A, et al. J Rheumatol. 1999 Apr;26(4):975-9. J Rheumatol. 1999. PMID: 10229431 Clinical Trial.
A value > or =0.60 was considered relevant]. Four clusters were identified (patient's subjective perception, inflammatory symptoms, metrology, laboratory data) with multiple correlation R2 revealing the most relevant variables to be the Bath Ankylosing Spondylitis Funct
A value > or =0.60 was considered relevant]. Four clusters were identified (patient's subjective perception, inflammatory symptoms
Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis.
Dougados M, Gueguen A, Nakache JP, Velicitat P, Zeidler H, Veys E, Calin A. Dougados M, et al. J Rheumatol. 1999 Apr;26(4):971-4. J Rheumatol. 1999. PMID: 10229430 Clinical Trial.
To evaluate C-reactive protein (CRP) as a potential useful criterion of symptomatic severity of ankylosing spondylitis (AS), we conducted both a cross sectional and a longitudinal (6 week) clinical study in 443 patients with axial involvement in AS. During th …
To evaluate C-reactive protein (CRP) as a potential useful criterion of symptomatic severity of ankylosing spondylitis (AS), we condu …
147 results
Jump to page
Feedback